Dystrophin-deficient mdx mice display a reduced life span and are susceptible to spontaneous rhabdomyosarcoma, FASEB J, vol.21, pp.2195-204, 2007. ,
Mice lacking dystrophin or alpha sarcoglycan spontaneously develop embryonal rhabdomyosarcoma with cancer-associated p53 mutations and alternatively spliced or mutant Mdm2 transcripts, Am J Pathol, vol.176, pp.416-450, 2010. ,
Dystrophin and dysferlin double mutant mice: a novel model for rhabdomyosarcoma, Cancer Genet, vol.205, pp.232-273, 2012. ,
DNA damage, somatic aneuploidy, and malignant sarcoma susceptibility in muscular dystrophies, PLoS Genet, 2011. ,
Muscular dystrophies share pathogenetic mechanisms with muscle sarcomas, Trends Mol Med, vol.19, pp.546-54, 2013. ,
Duchenne muscular dystrophy and concomitant metastatic alveolar rhabdomyosarcoma, J Pediatr Hematol Oncol, vol.21, pp.528-558, 1999. ,
Duchenne muscular dystrophy-rhabdomyosarcoma, ichthyosis vulgaris/acute monoblastic leukemia: association of rare genetic disorders and childhood malignant diseases, Med Pediatr Oncol, vol.39, pp.66-74, 2002. ,
Medulloblastoma in a child with Duchenne muscular dystrophy, Childs Nerv Syst, vol.23, pp.595-602, 2007. ,
Neuroblastoma in Duchenne muscular dystrophy, Pediatrics, vol.78, pp.1170-1171, 1986. ,
Liver function tests" are not always tests of liver function, Am J Hematol, vol.66, pp.46-54, 2001. ,
Anesthesia for Duchenne muscular dystrophy patients: case reports, Rev Bras Anestesiol, vol.55, pp.445-454, 2005. ,
Duchenne muscular dystrophy and acute lymphoblastic leukaemia, Haematologia (Budap), vol.21, pp.123-127, 1988. ,
Anaplastic medulloblastoma in a child with Duchenne muscular dystrophy, J Neurosurg Pediatr, vol.10, pp.21-25, 2012. ,
Possible clue for chromosomal assignment of the gene for facioscapulohumeral muscular dystrophy: a family with polyposis, Ann Neurol, vol.24, p.178, 1988. ,
The second family with facioscapulo-humeral muscular dystrophy and familial polyposis coli, Neurology, vol.39, p.404, 1989. ,
Unusual association of FSHD and extramedullary thoracic tumour in the same patient: a case report, Acta Myol, vol.28, pp.76-85, 2009. ,
Cancer risk among patients with myotonic muscular dystrophy, JAMA, vol.306, pp.2480-2486, 2011. ,
Increased cancer risks in myotonic dystrophy, Mayo Clin Proc, vol.87, pp.130-135, 2012. ,
Epigenetic mechanisms of facioscapulohumeral muscular dystrophy, Mutat Res, vol.647, pp.94-102, 2008. ,
FSHD: copy number variations on the theme of muscular dystrophy, JCB, vol.191, pp.1049-60, 2010. ,
Facioscapulohumeral muscular dystrophy, Neurotherapeutics, vol.5, pp.601-607, 2008. ,
URL : https://hal.archives-ouvertes.fr/hal-00770764
Common epigenetic changes of D4Z4 in contraction-dependent and contractionindependent FSHD, Hum Mutat, 2009. ,
Detailed cytogenetic and array analysis of pediatric primitive sarcomas reveals a recurrent CIC-DUX4 fusion gene event, Cancer Genet Cytogenet, vol.195, pp.1-11, 2010. ,
High prevalence of CIC fusion with doublehomeobox (DUX4) transcription factors in EWSR1-negative undifferentiated small blue round cell sarcomas, Genes Chromosom Cancer, vol.51, pp.207-225, 2012. ,
The CIC-DUX4 fusion transcript is present in a subgroup of pediatric primitive round cell sarcomas, Hum Pathol, vol.43, pp.180-189, 2012. ,
Fusion between CIC and DUX4 upregulates PEA3 family genes in Ewing-like sarcomas with t(4;19)(q35;q13) translocation, Hum Mol Genet, vol.15, pp.2125-2162, 2006. ,
Fusion of EWSR1 with the DUX4 facioscapulohumeral muscular dystrophy region resulting from t(4;22)(q35;q12) in a case of embryonal rhabdomyosarcoma, Cancer Genet Cytogenet, vol.195, pp.12-20, 2009. ,
URL : https://hal.archives-ouvertes.fr/hal-00435710
Hypermethylation of genomic 3.3-kb repeats is frequent event in HPV-positive cervical cancer, BMC Med Genomics, 2009. ,
Epigenetics of a tandem DNA repeat: chromatin DNaseI sensitivity and opposite methylation changes in cancers, Nucleic Acids Res, 2008. ,
Facioscapulohumeral muscular dystrophy (FSHD): an enigma unravelled?, Hum Genet, 2011. ,
Facioscapulohumeral muscular dystrophy and DUX4: breaking the silence, Trends Mol Med, vol.17, pp.252-260, 2011. ,
A nuclear matrix attachment site in the 4q35 locus has an enhancer-blocking activity in vivo: implications for the facio-scapulo-humeral dystrophy, Genome Res, vol.18, pp.39-45, 2008. ,
The Kruppel-like factor 15 as a molecular link between myogenic factors and a chromosome 4q transcriptional enhancer implicated in facioscapulohumeral dystrophy, J Biol Chem, vol.286, pp.44620-44651, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-02540056
Myoblasts from affected and non-affected FSHD muscles exhibit morphological 216 ª 2013 The Authors, John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine. differentiation defects. J Cell Mol Med, vol.14, pp.275-89, 2010. ,
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C (T)) Method, Methods, vol.25, pp.402-410, 2001. ,
, Statistiques avec Excel, 2000.
List of lists-annotated (LOLA): a database for annotation and comparison of published microarray gene lists, Gene, vol.360, pp.78-82, 2005. ,
bioDBnet: the biological database network, Bioinformatics, vol.25, pp.555-561, 2009. ,
Expression profiling of FSHD muscle supports a defect in specific stages of myogenic differentiation, Hum Mol Genet, vol.12, pp.2895-907, 2003. ,
Facioscapulohumeral muscular dystrophy (FSHD) myoblasts demonstrate increased susceptibility to oxidative stress, Neuromuscul Disord, vol.13, pp.322-355, 2003. ,
Parallel protein and transcript profiles of FSHD patient muscles correlate to the D4Z4 arrangement and reveal a common impairment of slow to fast fibre differentiation and a general deregulation of MyoD-dependent genes, Proteomics, vol.6, pp.5303-5324, 2006. ,
Isolation and characterization of mesoangioblasts from facioscapulohumeral muscular dystrophy muscle biopsies, Stem Cells, vol.25, pp.3173-82, 2007. ,
Expression profile of FSHD supports a link between retinal vasculopathy and muscular dystrophy, Neurology, vol.68, pp.569-77, 2007. ,
Expression profiling of FSHD-1 and FSHD-2 cells during myogenic differentiation evidences common and distinctive gene dysregulation patterns, PLoS ONE, 2011. ,
Transcriptional profiling in facioscapulohumeral muscular dystrophy to identify candidate biomarkers, Proc Natl Acad Sci USA, vol.109, pp.16234-16243, 2012. ,
Common human cancer genes discovered by integrated geneexpression analysis, PLoS ONE, vol.2, p.1149, 2007. ,
Identification of a gene expression signature common to distinct cancer pathways, Cancer Inform, vol.11, pp.139-185, 2012. ,
A census of human cancer genes, Nat Rev Cancer, vol.4, pp.177-83, 2004. ,
Common cancer biomarkers, Cancer Res, vol.66, pp.2953-61, 2006. ,
A gene expression profile of stem cell pluripotentiality and differentiation is conserved across diverse solid and hematopoietic cancers, Genome Biol, vol.13, p.71, 2012. ,
A transcriptional signature and common gene networks link cancer with lipid metabolism and diverse human diseases, Cancer Cell, vol.17, pp.348-61, 2010. ,
Largescale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression, Proc Natl Acad Sci USA, vol.101, pp.9309-9323, 2004. ,
Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks, Nat Med, vol.7, pp.673-682, 2001. ,
Diagnostic classification of cancer using DNA microarrays and artificial intelligence, Ann N Y Acad Sci, vol.1020, pp.49-66, 2004. ,
Mechanisms of genomic instabilities underlying two common fragile-site-associated loci, PARK2 and DMD, in germ cell and cancer cell lines, Am J Hum Genet, vol.87, pp.75-89, 2010. ,
A unifying genetic model for facioscapulohumeral muscular dystrophy, Science, vol.329, pp.1650-1653, 2010. ,
Facioscapulohumeral muscular dystrophy in mice overexpressing FRG1, Nature, vol.439, pp.973-980, 2006. ,
Alteration of expression of muscle specific isoforms of the fragile X related protein 1 (FXR1P) in facioscapulohumeral muscular dystrophy patients, J Med Genet, vol.45, pp.679-85, 2008. ,
Rbfox1 downregulation and altered calpain 3 splicing by FRG1 in a mouse model of Facioscapulohumeral muscular dystrophy (FSHD) ,
, PLoS Genet, 2013.
FRG1P-mediated aggregation of proteins involved in pre-mRNA processing, Chromosoma, vol.116, pp.53-64, 2007. ,
Aberrant and alternative splicing in cancer, Cancer Res, vol.64, pp.7647-54, 2004. ,
Pre-mRNA splicing and human disease, Genes Dev, vol.17, pp.419-456, 2003. ,
Molecular mechanisms responsible for aberrant splicing of SERCA1 in myotonic dystrophy type ,
, Hum Mol Genet, vol.16, pp.2834-2877, 2007.
Hypothesis: neoplasms in myotonic dystrophy, Cancer Causes Control, vol.20, pp.2009-2029, 2009. ,
Association between basal, squamous cell carcinomas, dysplastic nevi and myotonic muscular dystrophy indicates an important role of RNA-binding proteins in development of human skin cancer, Arch Dermatol Res, vol.302, pp.169-70, 2010. ,
Intrinsic epigenetic regulation of the D4Z4 macrosatellite repeat in a transgenic mouse model for FSHD, PLoS Genet, 2013. ,
Conditional over-expression of PITX1 causes skeletal muscle dystrophy in mice, Biol Open, vol.1, pp.629-668, 2013. ,
Myotonic dystrophy mouse models: towards rational therapy development, Trends Mol Med, vol.17, pp.506-523, 2011. ,
Imatinib attenuates severe mouse dystrophy and inhibits proliferation and fibrosis-marker expression in muscle mesenchymal progenitors, Neuromuscul Disord, vol.23, pp.349-56, 2013. ,
The anticancer drug tamoxifen counteracts the pathology in a mouse model of duchenne muscular dystrophy, Am J Pathol, vol.182, pp.485-504, 2013. ,
, The Authors, Journal of Cellular and Molecular Medicine, 2013.